These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 35506967)
1. Medication-related osteonecrosis of the jaw: A multifaceted diagnostic challenge. Mini review. Bonachea R; Katz J Am J Dent; 2022 Apr; 35(2):109-112. PubMed ID: 35506967 [TBL] [Abstract][Full Text] [Related]
2. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs. Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661 [TBL] [Abstract][Full Text] [Related]
3. Emerging antiresorptive medications and their potential implications for dental surgeries. Aminoshariae A; Donaldson M; Horan M; Mackey SA; Kulild JC; Baur D J Am Dent Assoc; 2022 Jul; 153(7):649-658. PubMed ID: 35277242 [TBL] [Abstract][Full Text] [Related]
4. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. Dodson TB Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw. Ruggiero SL Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329 [TBL] [Abstract][Full Text] [Related]
6. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review. Khominsky A; Lim M Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095 [TBL] [Abstract][Full Text] [Related]
7. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ). Otto S; Aljohani S; Fliefel R; Ecke S; Ristow O; Burian E; Troeltzsch M; Pautke C; Ehrenfeld M Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34065104 [TBL] [Abstract][Full Text] [Related]
8. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention. Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668 [TBL] [Abstract][Full Text] [Related]
9. Medication-Related Osteonecrosis of the Jaws in the Pediatric Population. Neal TW; Schlieve T J Oral Maxillofac Surg; 2022 Oct; 80(10):1686-1690. PubMed ID: 35931181 [TBL] [Abstract][Full Text] [Related]
10. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw. Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278 [TBL] [Abstract][Full Text] [Related]
11. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review. Kawahara M; Kuroshima S; Sawase T Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769 [TBL] [Abstract][Full Text] [Related]
12. [Progress on medication-related osteonecrosis of the jaw]. Wang QZ; Liu JY; Pan J Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):568-572. PubMed ID: 30465354 [TBL] [Abstract][Full Text] [Related]
13. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model). Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232 [No Abstract] [Full Text] [Related]
14. Antiresorptive Agents and Anti-Angiogenesis Drugs in the Development of Osteonecrosis of the Jaw. Allegra A; Innao V; Pulvirenti N; Musolino C Tohoku J Exp Med; 2019 May; 248(1):27-29. PubMed ID: 31080196 [TBL] [Abstract][Full Text] [Related]
15. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis. Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067 [TBL] [Abstract][Full Text] [Related]
16. Medication-related osteonecrosis of the jaw: A literature review and update. Kuroshima S; Al-Omari FA; Sasaki M; Sawase T Genesis; 2022 Sep; 60(8-9):e23500. PubMed ID: 36106755 [TBL] [Abstract][Full Text] [Related]
17. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)]. Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441 [TBL] [Abstract][Full Text] [Related]
18. Further development of the MRONJ minipig large animal model. Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745 [TBL] [Abstract][Full Text] [Related]
19. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study. Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738 [TBL] [Abstract][Full Text] [Related]
20. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents. Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]